文献速递乳腺CTMRUS乳腺X线

乳腺原发性神经内分泌癌与神经内分泌分化乳腺癌:组织病理学与影像学特征的关系

Primary neuroendocrine carcinomas of the breast and neuroendocrine differentiated breast cancers: Relationship between histopathological and radiological features.
PubMed 文献 · Eur J Radiol · 2022-01-04

回顾性分析2010至2021年105个乳腺病灶(神经内分泌分化乳腺癌44个、神经内分泌癌11个、无神经内分泌特征乳腺癌50个),比较乳腺X线、超声和MRI的BI-RADS特征。神经内分泌肿瘤患者年龄更大,典型恶性征象如不规则形、毛刺、结构扭曲、钙化、非平行生长、声影和腋窝淋巴结肿大均较少见;MRI强化方式和弥散受限无显著差异。结论认为乳腺神经内分泌癌趋向于表现更多良性影像特征。

要点

  • 乳腺神经内分泌癌和神经内分泌分化乳腺癌较少出现不规则形、毛刺、结构扭曲、可疑钙化及后方声影等典型恶性征象。
  • 与无神经内分泌特征乳腺癌相比,神经内分泌肿瘤更易表现为平行于皮肤的生长方向和缺乏腋窝淋巴结肿大。
  • MRI上两组在强化方式、时间-信号强度曲线和弥散受限方面无显著差异,诊断需结合病理。

核心结论

  • 乳腺神经内分泌癌和神经内分泌分化乳腺癌较少表现为典型恶性影像特征(不规则形、毛刺、可疑钙化、后方声影),与无神经内分泌特征乳腺癌相比趋向于更多良性影像表现;MRI强化方式、动力学曲线和弥散受限无显著差异。

研究设计与样本

  • 回顾性研究,2010至2021年共纳入105个乳腺病灶:神经内分泌分化乳腺癌44个、神经内分泌癌11个、无神经内分泌特征乳腺癌50个(从同一数据库随机选取);由两名乳腺放射科医师按BI-RADS第5版词典共识回顾评估乳腺X线、超声和MRI。

关键影像表现/征象

  • 乳腺X线上,不规则形在神经内分泌分化乳腺癌为7/20、神经内分泌癌为3/7,无神经内分泌特征乳腺癌为35/43(p < 0.001)。
  • 毛刺征在神经内分泌分化乳腺癌为2/20、神经内分泌癌为0/7,无神经内分泌特征乳腺癌为21/43(p < 0.001)。
  • 结构扭曲在神经内分泌分化乳腺癌为3/24、神经内分泌癌为0/9,无神经内分泌特征乳腺癌为31/50(p < 0.001)。
  • 钙化在神经内分泌分化乳腺癌为6/24、神经内分泌癌为0/9,无神经内分泌特征乳腺癌为27/50(p = 0.001)。
  • 超声上非平行于皮肤生长在神经内分泌分化乳腺癌为17/29、神经内分泌癌为4/9,无神经内分泌特征乳腺癌为35/42(p = 0.008);声影在神经内分泌分化乳腺癌为12/29、神经内分泌癌为1/9,无神经内分泌特征乳腺癌为29/42(p = 0.009);腋窝淋巴结肿大在神经内分泌分化乳腺癌为3/30、神经内分泌癌为1/9,无神经内分泌特征乳腺癌为21/50(p < 0.001)。

诊断标准与关键数值

  • 按神经内分泌标志物(突触素和嗜铬粒蛋白A)染色分为:局灶染色为神经内分泌分化乳腺癌,弥漫染色为神经内分泌癌。
  • 影像特征按BI-RADS第5版词典评估,包括形状、边缘、钙化、结构扭曲、生长方向、声影和腋窝淋巴结等。

临床应用与阅片要点

  • 阅片时注意乳腺神经内分泌肿瘤可能缺乏典型恶性征象(如毛刺、可疑钙化、结构扭曲和后方声影),避免因影像表现偏良性而低估恶性可能。
  • 超声上非平行于皮肤生长和腋窝淋巴结肿大在神经内分泌肿瘤中较少见,但并非不存在,仍需结合其他表现综合判断。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study wasto investigate whole-breast imaging findings (mammography, ultrasonography (US), magnetic resonance imaging (MRI),clinical, and histopathological findings of primary neuroendocrine carcinomas of the breast (NEC) and neuroendocrine differentiated breast cancers (NEBC).

METHODS: Patients withadiagnosis of breast cancer with histopathological neuroendocrine features between the years 2010 and 2021 were retrospectively screened.The lesions were divided into two main groups depending on staining with neuroendocrine markers (synaptophysin and chromogranin A). Those showing focal staining were categorized as NEBC while those with diffuse staining as NEC.The mammography, US, and MRI of the lesionswere reviewed in consensus by two breast radiologists in order to assess imaging featuresretrospectively according to the Breast Imaging Reporting and Data System (BI-RADS) 5th lexicon.The findings were compared with breast cancers without neuroendocrine features (BC-WNE) which were randomly selected from the same database.

RESULTS: A total of 105 lesions [NEBC (n = 44), NEC(n = 11), BC-WNE (n = 50)] were evaluated.Patients with neuroendocrine tumors were older (p < 0.001) than those with BC-WNE. Compared with BC-WNE tumors, radiological findings typical of malignancy such as irregular shape [NEBC (7/20); NEC(3/7) vs BC-WNE (35/43); p < 0.001], spiculation [NEBC (2/20); NEC(0/7) vs BC-WNE (21/43); p < 0.001], architectural distortion [(NEBC (3/24); NEC(0/9) vs BC-WNE (31/50); p < 0.001)], calcification [(NEBC (6/24), NEC(0/9) vs BC-WNE (n = 27/50); p = 0.001)] on mamography, non-parallel orientation to skin [(NEBC (n = 17/29), NEC(n = 4/9), BC-WNE (n = 35/42); p = 0.008)], acoustic shadowing [(NEBC (n = 12/29), NEC(1/9), BC-WNE (n = 29/42); p = 0.009)], axillary lymphadenopathy [(NEBC(n = 3/30), NEC(n = 1/9), BC-WNE (21/50); p < 0.001)]on US were less common features of the neuroendocrine carcinomas of breast. Aside from shape features, there was no significant difference in contrast pattern (p = 0.866), kinetic curve (p = 0.454) and diffusion restriction (p = 0.242) on MRI.

CONCLUSION: Characteristic malignant imaging features, including irregular shape, spiculated margins, suspicious calcifications, and posterior acoustic shadowing, are uncommon in neuroendocrine carcinomas of breast. These carcinomas tend to show more benign imaging features when compared with BC-WNE.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Kayadibi, Erginoz, Cavus, et al. Primary neuroendocrine carcinomas of the breast and neuroendocrine differentiated breast cancers: Relationship between histopathological and radiological features. Eur J Radiol. 2022. PMID: 35007984. doi:10.1016/j.ejrad.2021.110148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。